Melanoma: Cutaneous, Version 2.2026

Susan M. Swetter; Douglas Johnson; Mark R. Albertini; Christopher A. Barker; Sarah Bateni; Joel Baumgartner; Shailender Bhatia; Christopher Bichakjian; Genevieve Boland; Sunandana Chandra; David Chen; Bartosz Chmielowski; Jacob Choi; Dominick Dimaio; Roxana Dronca; Martin D. Fleming; Anjela Galan; Samantha Guild; Siwen Hu-Lieskovan; Giorgos Karakousis; Kari Kendra; Maija Kiuru; Julie R. Lange; Ryan Lanning; Theodore Logan; Miguel Materin; Kelly Nelson; Daniel Olson; Anthony J. Olszanski; Patrick A. Ott; Igor Puzanov; Luke Rothermel; April K. Salama; Adrienne Shannon; Rohit Sharma; Arun Singh; Andrew Stacey; Katy Tsai; Evan Wuthrick; Yan Xing; Nicole McMillian; Sara Espinosa

doi:10.6004/jnccn.2026.0027

Melanoma: Cutaneous, Version 2.2026

Susan M. Swetter
, Douglas Johnson
, Mark R. Albertini
, Christopher A. Barker
, Sarah Bateni
, Joel Baumgartner
, Shailender Bhatia
, Christopher Bichakjian
, Genevieve Boland
, Sunandana Chandra
, David Chen
, Bartosz Chmielowski
, Jacob Choi
, Dominick Dimaio
, Roxana Dronca
, Martin D. Fleming
, Anjela Galan
, Samantha Guild
, Siwen Hu-Lieskovan
, Giorgos Karakousis

Kari Kendra, Maija Kiuru, Julie R. Lange, Ryan Lanning, Theodore Logan, Miguel Materin, Kelly Nelson, Daniel Olson, Anthony J. Olszanski, Patrick A. Ott, Igor Puzanov, Luke Rothermel, April K. Salama, Adrienne Shannon, Rohit Sharma, Arun Singh, Andrew Stacey, Katy Tsai, Evan Wuthrick, Yan Xing, Nicole McMillian, Sara Espinosa

Medicine

Stanford University
Vanderbilt University
University of Wisconsin-Madison
Memorial Sloan-Kettering Cancer Center
University of Alabama at Birmingham
University of California at San Diego
Fred Hutchinson Cancer Research Center
University of Michigan, Ann Arbor
Mass General Cancer Center
Northwestern University
University of Washington
University of California at Los Angeles
University of Nebraska Medical Center
Mayo Clinic Rochester, MN
University of Tennessee Health Science Center
Yale University
AIM AT MELANOMA
University of Utah
University of Pennsylvania
Ohio State University
University of California at Davis
Johns Hopkins University
University of Colorado Anschutz Medical Campus
Indiana University Bloomington
Duke University
University of Texas MD Anderson Cancer Center
The University of Chicago
Fox Chase Cancer Center
Dana-Farber/Brigham and Women's Cancer Center
Case Western Reserve University
UT Southwestern Simmons Comprehensive Cancer Center
University of California at San Francisco
Moffitt Cancer Center
City of Hope National Med Center
National Comprehensive Cancer Network

Research output: Contribution to journal › Article › peer-review

3 Scopus citations

Abstract

The NCCN Guidelines for Melanoma: Cutaneous provide strategies for the diagnosis, treatment, and follow-up of patients with cutaneous melanoma, which is among the most common cancers in the United States. The outcome of cutaneous melanoma is significantly influenced by stage at initial presentation. Generally, localized disease and smaller primary tumors have been associated with more favorable prognosis. Thus, the select content featured in this issue focuses on risk factors associated with cutaneous melanoma development and which should be considered during an initial assessment. These include (1) phenotypic predispositions, (2) personal medical history or comorbidities, (3) genetic predispositions, and (4) environmental factors.

Original language	English
Pages (from-to)	272-277
Number of pages	6
Journal	JNCCN Journal of the National Comprehensive Cancer Network
Volume	24
Issue number	6
DOIs	https://doi.org/10.6004/jnccn.2026.0027
State	Published - Jun 2026

Access to Document

10.6004/jnccn.2026.0027

Cite this

Swetter, S. M., Johnson, D., Albertini, M. R., Barker, C. A., Bateni, S., Baumgartner, J., Bhatia, S., Bichakjian, C., Boland, G., Chandra, S., Chen, D., Chmielowski, B., Choi, J., Dimaio, D., Dronca, R., Fleming, M. D., Galan, A., Guild, S., Hu-Lieskovan, S., ... Espinosa, S. (2026). Melanoma: Cutaneous, Version 2.2026. JNCCN Journal of the National Comprehensive Cancer Network, 24(6), 272-277. https://doi.org/10.6004/jnccn.2026.0027

@article{f687e8cf9e424caabdfa6c3dfeba64b9,

title = "Melanoma: Cutaneous, Version 2.2026",

abstract = "The NCCN Guidelines for Melanoma: Cutaneous provide strategies for the diagnosis, treatment, and follow-up of patients with cutaneous melanoma, which is among the most common cancers in the United States. The outcome of cutaneous melanoma is significantly influenced by stage at initial presentation. Generally, localized disease and smaller primary tumors have been associated with more favorable prognosis. Thus, the select content featured in this issue focuses on risk factors associated with cutaneous melanoma development and which should be considered during an initial assessment. These include (1) phenotypic predispositions, (2) personal medical history or comorbidities, (3) genetic predispositions, and (4) environmental factors.",

author = "Swetter, \{Susan M.\} and Douglas Johnson and Albertini, \{Mark R.\} and Barker, \{Christopher A.\} and Sarah Bateni and Joel Baumgartner and Shailender Bhatia and Christopher Bichakjian and Genevieve Boland and Sunandana Chandra and David Chen and Bartosz Chmielowski and Jacob Choi and Dominick Dimaio and Roxana Dronca and Fleming, \{Martin D.\} and Anjela Galan and Samantha Guild and Siwen Hu-Lieskovan and Giorgos Karakousis and Kari Kendra and Maija Kiuru and Lange, \{Julie R.\} and Ryan Lanning and Theodore Logan and Miguel Materin and Kelly Nelson and Daniel Olson and Olszanski, \{Anthony J.\} and Ott, \{Patrick A.\} and Igor Puzanov and Luke Rothermel and Salama, \{April K.\} and Adrienne Shannon and Rohit Sharma and Arun Singh and Andrew Stacey and Katy Tsai and Evan Wuthrick and Yan Xing and Nicole McMillian and Sara Espinosa",

note = "Publisher Copyright: {\textcopyright} JNCCN{\textemdash}Journal of the National Comprehensive Cancer Network.",

year = "2026",

month = jun,

doi = "10.6004/jnccn.2026.0027",

language = "English",

volume = "24",

pages = "272--277",

journal = "JNCCN Journal of the National Comprehensive Cancer Network",

issn = "1540-1405",

publisher = "Harborside Press",

number = "6",

}

Swetter, SM, Johnson, D, Albertini, MR, Barker, CA, Bateni, S, Baumgartner, J, Bhatia, S, Bichakjian, C, Boland, G, Chandra, S, Chen, D, Chmielowski, B, Choi, J, Dimaio, D, Dronca, R, Fleming, MD, Galan, A, Guild, S, Hu-Lieskovan, S, Karakousis, G, Kendra, K, Kiuru, M, Lange, JR, Lanning, R, Logan, T, Materin, M, Nelson, K, Olson, D, Olszanski, AJ, Ott, PA, Puzanov, I, Rothermel, L, Salama, AK, Shannon, A, Sharma, R, Singh, A, Stacey, A, Tsai, K, Wuthrick, E, Xing, Y, McMillian, N & Espinosa, S 2026, 'Melanoma: Cutaneous, Version 2.2026', JNCCN Journal of the National Comprehensive Cancer Network, vol. 24, no. 6, pp. 272-277. https://doi.org/10.6004/jnccn.2026.0027

TY - JOUR

T1 - Melanoma

T2 - Cutaneous, Version 2.2026

AU - Swetter, Susan M.

AU - Johnson, Douglas

AU - Albertini, Mark R.

AU - Barker, Christopher A.

AU - Bateni, Sarah

AU - Baumgartner, Joel

AU - Bhatia, Shailender

AU - Bichakjian, Christopher

AU - Boland, Genevieve

AU - Chandra, Sunandana

AU - Chen, David

AU - Chmielowski, Bartosz

AU - Choi, Jacob

AU - Dimaio, Dominick

AU - Dronca, Roxana

AU - Fleming, Martin D.

AU - Galan, Anjela

AU - Guild, Samantha

AU - Hu-Lieskovan, Siwen

AU - Karakousis, Giorgos

AU - Kendra, Kari

AU - Kiuru, Maija

AU - Lange, Julie R.

AU - Lanning, Ryan

AU - Logan, Theodore

AU - Materin, Miguel

AU - Nelson, Kelly

AU - Olson, Daniel

AU - Olszanski, Anthony J.

AU - Ott, Patrick A.

AU - Puzanov, Igor

AU - Rothermel, Luke

AU - Salama, April K.

AU - Shannon, Adrienne

AU - Sharma, Rohit

AU - Singh, Arun

AU - Stacey, Andrew

AU - Tsai, Katy

AU - Wuthrick, Evan

AU - Xing, Yan

AU - McMillian, Nicole

AU - Espinosa, Sara

PY - 2026/6

Y1 - 2026/6

N2 - The NCCN Guidelines for Melanoma: Cutaneous provide strategies for the diagnosis, treatment, and follow-up of patients with cutaneous melanoma, which is among the most common cancers in the United States. The outcome of cutaneous melanoma is significantly influenced by stage at initial presentation. Generally, localized disease and smaller primary tumors have been associated with more favorable prognosis. Thus, the select content featured in this issue focuses on risk factors associated with cutaneous melanoma development and which should be considered during an initial assessment. These include (1) phenotypic predispositions, (2) personal medical history or comorbidities, (3) genetic predispositions, and (4) environmental factors.

AB - The NCCN Guidelines for Melanoma: Cutaneous provide strategies for the diagnosis, treatment, and follow-up of patients with cutaneous melanoma, which is among the most common cancers in the United States. The outcome of cutaneous melanoma is significantly influenced by stage at initial presentation. Generally, localized disease and smaller primary tumors have been associated with more favorable prognosis. Thus, the select content featured in this issue focuses on risk factors associated with cutaneous melanoma development and which should be considered during an initial assessment. These include (1) phenotypic predispositions, (2) personal medical history or comorbidities, (3) genetic predispositions, and (4) environmental factors.

UR - https://www.scopus.com/pages/publications/105042354925

U2 - 10.6004/jnccn.2026.0027

DO - 10.6004/jnccn.2026.0027

M3 - Article

C2 - 42297031

AN - SCOPUS:105042354925

SN - 1540-1405

VL - 24

SP - 272

EP - 277

JO - JNCCN Journal of the National Comprehensive Cancer Network

JF - JNCCN Journal of the National Comprehensive Cancer Network

IS - 6

ER -

Melanoma: Cutaneous, Version 2.2026

Abstract

Access to Document

Other files and links

Fingerprint

Cite this